🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, doctors and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering products of uncertain source.

Some experts said the demand for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down problematic content and prohibited related keywords and search suggestions. The organization said it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, glowing reviews and detailed guides for mixing or administering at residence.

Within moments of entering one group, a vendor posted contact information, where the majority of transactions take place. The seller provided an guidebook and promised shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Inside these communities, posts show black plastic parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how long a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram said it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Even if the research behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen patients injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to possibly significant health risks”.